| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate |
2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be3c6c34d2e5351dfa3b1d4437996c5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a13be73a2a26826ce2c7c000af50b31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f726e421b96ed20b2e27abce6f96221 |
| publicationDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2595407-T3 |
| titleOfInvention |
Combination of panobinostat and ruxolitinib in the treatment of cancer, such as a myeloproliferative neoplasm |
| abstract |
A composition comprising Compound A ((R) -3- (4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1-H-pyrazol-1-yl) -3-cyclopentylpropanonitrile) of Formula (A): ** Formula ** or a pharmaceutically acceptable salt thereof; and Compound B (N-hydroxy-3- [4 - [[[2- (2-methyl-1H-indol-3-yl) -ethyl] -amino] methyl] phenyl] -2E-2-propenamide) of Formula (B): ** Formula ** or a pharmaceutically acceptable salt thereof, for use in the treatment of a cancer, in which the cancer is myeloproliferative neoplasia or multiple myeloma. |
| priorityDate |
2011-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |